The Risk of Bleeding in Patients Receiving Ibrutinib Combined with Novel Direct Oral Anticoagulants
Year: 2019
Type: conference-abstract
Source: Blood
Language: English
Subfield: Hematology
Field: Medicine
Domain: Health Sciences
Keywords: ibrutinib, direct oral anticoagulants, major bleeding, bleeding risk, B-cell lymphoproliferative disorders, chronic lymphocytic leukemia, mantle cell lymphoma, apixaban, rivaroxaban, dabigatran, platelet dysfunction, BTK inhibitors, drug-drug interactions, atrial fibrillation, venous thromboembolism
Open Access status: closed
OpenAlex ID: W2989170640
